Zobrazeno 1 - 8
of 8
pro vyhledávání: '"B. G. Kirodian"'
Publikováno v:
Proceedings of Indian National Science Academy, Vol 68, Iss 4B (2015)
Liposomal Drug Delivery System from Laboratory to Patients: Our Experience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::c09ede227409f9e06d7a9c7144659c5c
https://insa.nic.in/writereaddata/UpLoadedFiles/PINSA/Vol68B_2002_4_Art02.pdf
https://insa.nic.in/writereaddata/UpLoadedFiles/PINSA/Vol68B_2002_4_Art02.pdf
Publikováno v:
Indian pediatrics. 40(6)
A liposomal amphotericin B preparation (L-AMP-LRC-1) has been developed and tested successfully in adults by us. This preparation was administered to 23 neonates with candidiasis in an open phase II study. All the 14 assessable patients responded com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::851dafc640d7b2779120e15de60adb8b
https://pubmed.ncbi.nlm.nih.gov/15181316
https://pubmed.ncbi.nlm.nih.gov/15181316
Publikováno v:
The Journal of the Association of Physicians of India. 50(5)
To compare conventional amphotericin B (c-amp B) and liposomal amphotericin B (L-AMP-LRC-1-India) in patients with systemic fungal infection in open, randomized, comparative, laboratory blind, phase III safety and efficacy study.Formulation of liposo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::20d4ccfe5afb7cf78b9d147d818c56ae
https://pubmed.ncbi.nlm.nih.gov/12186120
https://pubmed.ncbi.nlm.nih.gov/12186120
Publikováno v:
The Journal of the Association of Physicians of India. 50
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::03063305d65a359adfe0635da3518988
https://pubmed.ncbi.nlm.nih.gov/12164423
https://pubmed.ncbi.nlm.nih.gov/12164423
Publikováno v:
The Journal of the Association of Physicians of India. 49
Four patients with cryptococcal meningitis were successfully treated with liposomal amphotericin B prepared at our institute using Soya phosphatidylcholine and cholesterol. In one patient, response with 1 mg/kg/day treatment was poor. However, on inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1ca7c1d2632df682a53a6be3b00a8747
https://pubmed.ncbi.nlm.nih.gov/11868862
https://pubmed.ncbi.nlm.nih.gov/11868862
Publikováno v:
Indian pediatrics. 39(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::118a577173ada6bc9073e18a713c523a
https://pubmed.ncbi.nlm.nih.gov/11867850
https://pubmed.ncbi.nlm.nih.gov/11867850
Publikováno v:
Transactions of the Royal Society of Tropical Medicine and Hygiene. 93(3)
Efficacy and tolerability of liposomal amphotericin B (L-AMP-LRC-1; developed in India by the Liposome Clinical Pharmacology Centre, Mumbai, and the Liposome Research Centre, New Delhi) were assessed in 63 patients suffering from visceral leishmanias
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1feab4105af2392e89c0593c3c50a51f
https://pubmed.ncbi.nlm.nih.gov/10492769
https://pubmed.ncbi.nlm.nih.gov/10492769
Autor:
N. J. Gogtay, S. S. Dalvi, R. B. Mhatre, B. G. Kirodian, A. H. Gupta, S. P. Jadhav, N. A. Kshirsagar
Publikováno v:
Therapeutic Drug Monitoring; Apr2003, Vol. 25 Issue 2, p215-220, 6p